Evidence map›Paper›PMID 41683678›Full record

ReviewInternational journal of molecular sciences2026

New Insights into Neuromuscular Junction Biology: Evidence from Human and Animal Research.

Zhanyang Liang, Xiaoying Chen, Mahtab Nourbakhsh

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhanyang LiangInstitute of Pathology, RWTH Aachen University Hospital, 52074 Aachen, Germany.
Xiaoying ChenInstitute of Pathology, RWTH Aachen University Hospital, 52074 Aachen, Germany.ORCID 0009-0002-3182-0856
Mahtab NourbakhshInstitute of Pathology, RWTH Aachen University Hospital, 52074 Aachen, Germany.ORCID 0000-0003-4102-0748

Funding

China Scholarship Council 202206170014Guangzhou Panyu Fifth People's Hospital Scholarship 440181198912140017START Grants from RWTH Aachen University Hospital 111/25
6 · The paper itself

Abstract

Neuromuscular junctions (NMJs) are highly specialized synapses that enable efficient communication between motor neurons and skeletal muscle fibers. Impaired formation or maintenance of NMJs is implicated in the pathogenesis of multiple neuromuscular disorders and contributes to age-related declines in skeletal muscle mass and strength. NMJ functionality is governed by complex regulatory crosstalk among different cells and is mediated by a diverse network of proteins. Moreover, immune cells often reside at NMJs and exhibit phenotypically different characteristics depending on the regenerative state of the muscle. These complex interfaces have posed a significant challenge for elucidating pathogenic mechanisms and developing biomarkers or effective targeted treatments. Many animal models have been developed to address this challenge by characterizing the fundamental structural features of neuromuscular junctions (NMJs) and their transmission capacity under both healthy and disease conditions. In contrast, studies of human NMJs remain limited, although emerging evidence is increasingly revealing substantial morphological and functional differences from animal NMJs. This review provides an overview of animal research on NMJs over the past decades, highlighting interspecies differences and key advances in our understanding of human NMJs.

Indexed as

Neuromuscular JunctionAnimalsHumansMuscle, SkeletalSynaptic Transmissionacetylcholine receptorneuromuscular junctionregenerationremodelingsynaptic vesicle proteintransduction

Identifiers

PMID41683678
PMCPMC12898414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.